Medical technology group Brasseler releases preliminary results for fiscal year 2025

Lemgo, 07.05.2026

The medical technology group Brasseler has released its preliminary results for the 2025 fiscal year. In a challenging economic environment, the company generated net revenue of just under 236 million euros. After adjusting for currency effects, revenue growth stood at 1.0%, falling short of expectations. Rising costs, increasing competition, and international political influences shaped business performance in 2025. Brasseler used the year to consistently pursue strategic initiatives. These showed initial promising results in selected markets. In 2026, management expects further positive momentum for competitiveness, efficiency, and customer focus. However, ongoing geopolitical crises pose risks.

Komet Medical: Growth thanks to strategic positioning

The Komet Medical business unit continued its successful performance, achieving 6.5% growth. Under this brand, the company operates as one of the leading contract development and manufacturing organizations (CDMO) for bone surgery cutting instruments. The products are used primarily in ENT and neurosurgery, as well as in orthopedics, traumatology, and dental implantology.

This positive performance is attributable, on the one hand, to consistently high demand in these product segments, and on the other hand, to the continued impact of the strategic positioning initiated in 2021. In addition to top-tier manufacturing, Komet Medical supports its major international customers with a range of services, such as packaging design and regulatory consulting.

“Komet Medical remains a key driver of growth for the Brasseler Group holding long-term potential. At the same time, it underscores how important it is to consistently expand our international footprint to work directly with our customers. Rising costs, including those resulting from tariffs in the U.S., are increasing the pressure to scrutinize and consistently optimize our structures,” says Stephan Köhler, Chairman of the Management Board.

Komet Dental: stagnation and initial signs of realignment

In Komet Dental, the largest business division, revenue stagnated in 2025. While performance fell short of expectations, particularly in international direct markets, the Germany/Austria region was able to stabilize the division through targeted measures and achieve its targets for the first time in quite some time.

As in the previous year, this development is characterized by an overall weak market environment, persistently high competitive pressure on the premium segment, and rising costs, including those driven by U.S. tariffs, raw material prices, and personnel costs. At the same time, Brasseler is strengthening international cooperation between the headquarters in Lemgo and the sales subsidiaries.

Internationalization and innovation remain at the heart of the company’s efforts. Brasseler is driving targeted innovation through system solutions such as “EnDrive”– which won the Red Dot Award – for root canal treatments; product solutions like Rocky, an instrument for removing hard all-ceramic crowns; and the expansion of a comprehensive continuing education program for dentists, along with a state-of-the-art training center in Verona. For these achievements, the company was awarded the TOP 100 seal for innovative medium-sized companies for the third time in early 2026, following awards in 2022 and 2023. The development of the sales company established in the UK in early 2025 exceeded expectations in its first year and is seen as another positive sign.

Management looks ahead to 2026 with cautious optimism

Brasseler is cautiously optimistic about the 2026 fiscal year. Although the market environment remains challenging, the company expects further growth. In addition, the measures implemented are proving effective and will be further advanced in 2026. Innovations in the dental sector, to be presented at the world’s leading trade fair, IDS, in 2027, as well as process optimizations that increase efficiency across all business areas, are expected to provide additional momentum.

“The overall conditions, particularly in Germany, will not improve in the short term and give us cause for concern regarding our long-term competitiveness,” said Stephan Köhler. “This makes it all the more important that, in addition to innovations in productivity and cost management, we continue to make progress in order to achieve our earnings targets. Only in this way can we lay the foundation for investments and further growth.”